Dr. Xuetao Cao is the President of the Nankai University and the Director of Center for Immunotherapy, Chinese Academy of Medical Sciences (CAMS), China. He has been Professor and Director of China’s National Key Laboratory of Medical Immunology since 2006 and was elected to the Chinese Academy of Engineering in 2005, German Academy of Sciences in 2013, US National Academy of Medicine in 2016, American Academy of Arts and Sciences in 2017. He is also the Secretary General of the Federation of Immunological Societies of Asia-Oceania (FIMSA) and the President of Chinese Society of Biomedical Engineering.
His major research interests include innate immunity and inflammation, cancer immunotherapy. His group has independently identified 22 novel molecules from human dendritic cell (DC), also identified a new regulatory DC subset. His group has been heading Phase III clinical trial of DC-based cancer chemoimmunotherapy. Recently his group identified important sensors and regulators of DC/macrophages-mediated antiviral innate immune response. As corresponding author, he published more than 270 original papers in peer-reviewed journals.
« Go Back